September 2023
1. MOLINA E, Garcia-Gutierrez L, Junco V, Perez-Olivares M, et al
   MYC directly transactivates CR2/CD21, the receptor of the Epstein-Barr virus, enhancing the viral infection of Burkitt lymphoma cells.
   Oncogene. 2023 Sep 29. doi: 10.1038/s41388-023-02846.
   

   >> Share

   
   August 2023
2. DIEPSTRATEN ST, La Marca JE, Chang C, Young S, et al
   BCL-W makes only minor contributions to MYC-driven lymphoma development.
   Oncogene. 2023 Aug 11. doi: 10.1038/s41388-023-02804.
   

   >> Share

   
   June 2023
3. ZHAO S, Li J, Xia Q, Liu K, et al
   New perspectives for targeting therapy in ALK-positive human cancers.
   Oncogene. 2023;42:1959-1969.
   

   >> Share

   
   May 2023
4. ZHENG J, Wang Z, Pan X, Zhang Z, et al
   DNMT3A(R882H) accelerates angioimmunoblastic T-cell lymphoma in mice.
   Oncogene. 2023 May 1. doi: 10.1038/s41388-023-02699.
   

   >> Share

   
   February 2023
5. WU W, Lu P, Patel P, Ma J, et al
   SHP1 loss augments DLBCL cellular response to ibrutinib: a candidate predictive biomarker.
   Oncogene. 2023;42:409-420.
   

   >> Share

   
   September 2022
6. WINKLER R, Magdefrau AS, Piskor EM, Kleemann M, et al
   Targeting the MYC interaction network in B-cell lymphoma via histone deacetylase 6 inhibition.
   Oncogene. 2022 Sep 6. pii: 10.1038/s41388-022-02450.
   

   >> Share

   
   June 2022
7. HANG X, Zhao L, Wu B, Li S, et al
   BCL-2 isoform beta promotes angiogenesis by TRiC-mediated upregulation of VEGF-A in lymphoma.
   Oncogene. 2022 Jun 14. pii: 10.1038/s41388-022-02372.
   

   >> Share

   
   March 2022
8. SUN R, Lei C, Chen L, He L, et al
   Alcohol-driven metabolic reprogramming promotes development of RORgammat-deficient thymic lymphoma.
   Oncogene. 2022 Mar 4. pii: 10.1038/s41388-022-02257.
   

   >> Share

   
   January 2022
9. FIDYT K, Pastorczak A, Cyran J, Crump NT, et al
   Potent, p53-independent induction of NOXA sensitizes MLL-rearranged B-cell acute lymphoblastic leukemia cells to venetoclax.
   Oncogene. 2022 Jan 28. pii: 10.1038/s41388-022-02196.
   

   >> Share

   
   November 2021
10. YIN L, Zeng Y, Zeng R, Chen Y, et al
    Protein kinase RNA-activated controls mitotic progression and determines paclitaxel chemosensitivity through B-cell lymphoma 2 in ovarian cancer.
    Oncogene. 2021 Nov 19. pii: 10.1038/s41388-021-02117.
    

    >> Share

    
    
11. BERDITCHEVSKI F, Fennell E, Murray PG
    Calcium-dependent signalling in B-cell lymphomas.
    Oncogene. 2021;40:6321-6328.
    

    >> Share

    
    
12. TU R, Kang W, Yang M, Wang L, et al
    USP29 coordinates MYC and HIF1alpha stabilization to promote tumor metabolism and progression.
    Oncogene. 2021;40:6417-6429.
    

    >> Share

    
    May 2021
13. KUNOU S, Shimada K, Takai M, Sakamoto A, et al
    Exosomes secreted from cancer-associated fibroblasts elicit anti-pyrimidine drug resistance through modulation of its transporter in malignant lymphoma.
    Oncogene. 2021 May 16. pii: 10.1038/s41388-021-01829.
    

    >> Share

    
    April 2021
14. ZHAO LN, Bjorklund M, Caldez MJ, Zheng J, et al
    Therapeutic targeting of the mitochondrial one-carbon pathway: perspectives, pitfalls, and potential.
    Oncogene. 2021;40:2339-2354.
    

    >> Share

    
    March 2021
15. AHMED SF, Buetow L, Gabrielsen M, Lilla S, et al
    E3 ligase-inactivation rewires CBL interactome to elicit oncogenesis by hijacking RTK-CBL-CIN85 axis.
    Oncogene. 2021;40:2149-2164.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share